Compugen Ltd (Israel) Financial Indicators Patterns

CGEN -- Israel Stock  

ILS 1,314  34.00  2.52%

We suggest you to use Compugen Ltd fundamental analysis to see if markets are presently mispricing the company. In plain English you can use it to find out if Compugen Ltd is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. . We found twenty-five available fundamental indicators for Compugen Ltd which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Compugen Ltd fundamentals including its Shares Outstanding, Revenue, EBITDA, as well as the relationship between Price to Sales and Gross Profit . Use Compugen Ltd to protect against small markets fluctuations. The stock experiences unexpected downward movement. The market is reacting to new fundamentals. Check odds of Compugen Ltd to be traded at S1261.44 in 30 days

Compugen Ltd Company Summary

Compugen Ltd., a therapeutic discovery company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel and Europe. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel. Compugen Ltd operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 101 people.

Compugen Ltd Operating Margin vs EBITDA

Compugen Ltd is number one stock in operating margin category among related companies. It is number one stock in ebitda category among related companies .

Compugen Ltd Market Fundamentals

 Change(%) 2.52%

Compugen Ltd Total Assets Over Time

Distress Rating

Compugen Ltd Financial Distress Probability

Chance of Financial Distress
Compugen Ltd has more than 52 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Compare Compugen Ltd

Compare Compugen Ltd To Peers

Compugen Ltd Opportunity Range

October 21, 2018 Opportunity Range

Check also Trending Equities. Please also try Equity Analysis module to research over 250,000 global equities including funds, stocks and etfs to find investment opportunities.